A. Heisel et J. Jung, The atrial defibrillator: A stand-alone device or part of a combined dual-chamber system?, AM J CARD, 83(5B), 1999, pp. 218D-226D
Citations number
119
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Atrial fibrillation (AF) is an extremely common arrhythmia seen in clinical
practice. Because of the limited efficacy of traditional therapeutic strat
egies to restore and maintain normal sinus rhythm, several nonpharmacologic
options have evolved. The promising results achieved with internal atrial
defibrillation have facilitated the development of an implantable atrial de
fibrillator. Preliminary results obtained from an initial study on a small
number of highly selected patients with refractory AF suggest that atrial d
efibrillation can be performed effectively and safely with adequate patient
tolerance by using a stand-alone device. The extension of this therapy wil
l depend on the results of well-designed prospective studies comparing this
new therapeutic option with traditional methods. Several acute studies hav
e shown that internal conversion of AF is feasible at low energies with cur
rent endocardial transvenous lead configurations primarily designed for ven
tricular defibrillation, bur long-term efficacy has, to date, only been dem
onstrated with atrial implantable defibrillator lead systems. As AF is a fr
equent arrhythmia in implantable cardioverter defibrillator (ICD) recipient
s, it would seem desirable to incorporate the capability for atrial defibri
llation into an ICD. Clinical studies have shown that an atrial defibrillat
or, as part of a combined dual-chamber ICD system, may not require a potent
ially complicated switching network for establishing different electrode co
nfigurations for atrial and ventricular tachyarrhythmia. The efficacy in at
rial cardioversion of such a combined, less complex device seems to be as h
igh as reported for a pure atrial defibrillator, but generally at somewhat
higher energy requirements. The results of further investigations will show
whether a dual-chamber cardioverter defibrillator would be of clinical rel
evance in patients with ventricular and supraventricular tachyarrhythmia. (
C) 1999 by Excerpta Medica, Inc.